| Line Item | 2024-02-28 | Y/Y |
|---|---|---|
| Cost of Revenue | $5K | -70.9% |
| Gross Profit | $5K | +171.0% |
| R&D Expense | $0 | — |
| SG&A Expense | $1.0M | -16.6% |
| Operating Income | -$2.2M | +33.1% |
| Net Income | -$2.5M | +30.4% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2024-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2K | -87.5% |
| Accounts Receivable | $3K | +80.4% |
| Inventory | $55K | +5560.5% |
| Current Assets | $70K | +100.4% |
| Total Assets | $221K | -64.3% |
| Current Liabilities | $2.1M | +24.2% |
| Total Liabilities | $2.2M | +28.7% |
| Line Item | 2024-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$423K | +48.2% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $411K | -50.5% |
| Stockholders' Equity |
| -$2.0M |
| -81.0% |